Clinical Trial Update: The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating prednisone plus recombinant human thrombopoietin for immune thrombocytopenia in pregnancy; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• PREDNISONE (Prednisone)
• recombinant human thrombopoietin (recombinant human thrombopoietin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: UNKNOWN